Anti-CD19 chimeric antigen receptor T-cell therapy in acute lymphocytic leukaemia: a systematic review and meta-analysis - The Lancet Haematology
Human T Cells Expressing a CD19 CAR-T Receptor Provide Insights into Mechanisms of Human CD19-Positive β Cell Destruction - ScienceDirect
CD19-targeted CAR T cells in refractory antisynthetase syndrome - The Lancet
FDA Approves Second CAR T-Cell Therapy - NCI
Imaging CAR T cell therapy with PSMA-targeted positron emission tomography | Science Advances
When CAR T cell therapy crashes
CD19 CAR T Cells Expressing IL-12 Eradicate Lymphoma in Fully Lymphoreplete Mice through Induction of Host Immunity: Molecular Therapy - Oncolytics
Frontiers | Mechanisms of Relapse After CD19 CAR T-Cell Therapy for Acute Lymphoblastic Leukemia and Its Prevention and Treatment Strategies
High-Affinity CD19 for CAR-T Cell Therapy
CD19-CAR-T Cells | Encyclopedia MDPI
Professor John G Gribben explains why CART-cell therapy has the potential to revolutionise cancer treatment. | Middle East Medical Portal
Donor-derived CD19 CAR-T cell therapy of relapse of CD19-positive B-ALL post allotransplant | Leukemia
CAR T Cells: Engineering Immune Cells to Treat Cancer - NCI
Mechanisms underlying CD19-positive ALL relapse after anti-CD19 CAR T cell therapy and associated strategies | Biomarker Research | Full Text
Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic Cancer: Molecular Therapy
CASI Pharmaceuticals | CNCT19
Anti-CD19 CAR T cells potently redirected to kill solid tumor cells | PLOS ONE
The CAT's meow: low-affinity CD19 CAR T cells show strong response with low toxicity in pediatric patients with ALL
JCI - HIV-specific CAR T cells return to the clinic
CD19-redirected chimeric antigen receptor-modified T cells: a promising immunotherapy for children and adults with B-cell acute lymphoblastic leukemia (ALL) - Sarah K. Tasian, Rebecca A. Gardner, 2015
Cells | Free Full-Text | Sensitivity and Specificity of CD19.CAR-T Cell Detection by Flow Cytometry and PCR
CAR T Cells: Second-Line Treatment Option for NHL? - NCI
Cancer immunotherapy with CAR-T cells – behold the future | RCP Journals
